Benin Joseph

Everyone chases a fat pipeline. Yet over the last decade, pipeline volume has decoupled from actual market returns. Why? Because "unmet needs" are moving targets, constantly disrupted by tech, competition, and patient diversity. Today, market survival requires assets that can withstand these harsh realities. The new gold standard isn't just finding a niche unmet need; it’s developing a compound that works across multiple pathologies and diverse patient profiles—the Humira model. That is why...

Antibody therapies need evaluation of safety efficacy in physiological models to gain maximum translation benefit. Towards such, ADCs...

Fish swim against water current to spawn, feed and to stay within a particular habitat. This natural motion against water current is...